Robyn MacQuarrie explains why she will continue to prescribe Viagra instead of Addyi to treat some women’s sexual dysfunction.
Tamara Kayali Browne suggests that the diagnosis of female sexual desire disorder is problematic.
Maya J. Goldenberg challenges the role of science in policy debates.
Adriane Fugh-Berman and Alessandra Hirsch consider the sexist roots and implications of flibanserin.
Beth Palmer discusses the potential for improved access to abortion with Mifepristone
Impact Ethics 